NEWFlashcards for any set of questions, quick-reference tables for breast, lung and prostate, and a month of access for every colleague you refer. See what changed

Lower GI: Colorectal molecular markers (MMR/MSI)

Free question published 10 November 2026

Lower GIColorectal molecular markers (MMR/MSI)

A 47-year-old woman presents with newly diagnosed, previously untreated metastatic colorectal cancer. Tumour testing shows mismatch-repair deficiency with high microsatellite instability (dMMR/MSI-high). She is fit for systemic therapy. What is the most appropriate first-line systemic treatment?

  1. AFOLFIRI plus cetuximab
  2. BEncorafenib plus cetuximab
  3. CPembrolizumab monotherapy
  4. DSingle-agent capecitabine
  5. EFOLFOX plus bevacizumab

Why C is correct

KEYNOTE-177 showed that first-line pembrolizumab was superior to chemotherapy in MSI-high/dMMR metastatic colorectal cancer, with a median progression-free survival of 16.5 versus 8.2 months (HR 0.60, P=0.0002) and far less grade 3 or higher toxicity. Pembrolizumab monotherapy is the preferred first-line option for this molecular subgroup.

And why the others are not

  • AIncorrect. Anti-EGFR therapy depends on RAS status and is not the first choice in MSI-high disease where immunotherapy is superior.
  • BIncorrect. Encorafenib plus cetuximab is for BRAF V600E-mutant disease, not selected by MMR/MSI status.
  • DIncorrect. Single-agent capecitabine is inadequate for a fit patient with metastatic disease and ignores the MSI-high indication for immunotherapy.
  • EIncorrect. Chemotherapy plus bevacizumab is the comparator that pembrolizumab outperformed in this molecular subgroup.

Source KEYNOTE-177 — first-line pembrolizumab versus chemotherapy in MSI-high/dMMR metastatic colorectal cancer — Andre T, Shiu KK, Kim TW, et al. Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer (KEYNOTE-177). N Engl J Med. 2020;383:2207-2218.

Sitting in February? Follow the twenty-week plan.

2,500+ cited questions like this one are waiting in the vault.

See plans and pricing